Efficacy of Oral Isotretinoin in Combination with Desloratadine in the Treatment of Acne Vulgaris at Al-Thawrah General Hospital, Sana’a, Yemen
DOI:
https://doi.org/10.65693/masj.2023.v2i1.23الكلمات المفتاحية:
Acne vulgaris, Acne lesion, GAGS score.الملخص
Background: Acne vulgaris is one of the most common skin problems in adult life, especially in adolescents.
Objective: This study aimed to evaluate the efficacy of oral isotretinoin in combination with desloratadine in the treatment of acne vulgaris at Al-Thawra General Hospital, Sana’a.
Methods: The study was designed as a prospective comparative clinical trial carried out in the Department of Dermatology, Al-Thawrah General Hospital, Sana’a during the period from Jan. to June 2019. The data were collected from each patient after verbal consent. All patients (60 pt.) were randomized into 2 equal groups (study group and control group). The mean age of the study group was 27.47 ± 4.249 year while 24.07 ± 3.393 year of the control group. Both groups were treated with isotretinoin 20mg per day for 16 weeks. The study group (combined treatment) received 5mg desloratadine daily in 16 weeks. The follow-up was carried in weeks (2, 4, 8, 12, 16) for acne lesion, GAGS score, side effects of drugs and outbreak of acne.
Results: This study found that females were more affected than males and acne lesion at 16 weeks was 16.7 % in the study group in contrast to 40.0 % in the control group. After 16 weeks of treatment, GAGS score showed that both groups had good outputs response to therapy with 86.7% excellent and 13.3% good in the study group compared to 56.7%, excellent, and 40 % good response to therapy. Whereas at 16 weeks most patients had no outbreak (86.7 % in the study group and 53.3 % in the control group), 3% in the study group and 46.7 % in the control group had mild outbreak with > 5 nodules. This study observed only minor side effects of desloratadine among the study group, such as headache and self-limited infection. Side effects of isotretinoin declined more rapidly when desloratadine was added. In contrast, this study showed that 10 % of patients had chelitis, conjunctivitis and 13.3 % of them had priorities at 16 weeks.
Conclusion: This study showed that adding oral desloratadine to the oral isotretinoin provides a better outcome and advantage in terms of efficacy and tolerability than isotretinoin treatment alone.
المراجع
1. Thappa D, Adityan B, Kumari R. Scoring Systems in Acne Vulgaris. Indian J Dermatol Ve 2009; 75(3): 323–326p.
2. Benner N; Sammons D. Overview of the Treatment of Acne Vulgaris, Osteopath Family Physic 2013; 5(5): 185–190p.
3. Harper JC. Acne Vulgaris, eMedicine, 2009.
4. Taylor M, Gonzalez M, Porter R. Pathways to Inflammation: Acne Pathophysiology, Eur J Dermatol 2011; 21(3): 323–333p.
5. Dawson AL, Dellavalle RP. Acne Vulgaris, BMJ 2013; 346: f2634p.
6. Berlin DJ, Goldberg AL. Acne and Rosacea Epidemiology, Diagnosis and Treatment, London: Manson Pub, 2012, 8p.
7. Spencer EH, Ferdowsian HR, Barnard ND. Diet and Acne: A Review of the Evidence, Int J Dermatol 2009; 48(4): 339–347p.
8. James WD. Acne, New Engl J Med 2005; 352(14): 1463–1472p.
9. Hsu A, Kenneth J. Manual of Dermatologic Therapeutics, Lippincott Williams &
Wilkins, 2007.
10. Laurence A. Looking Good, the Australian Guide to Skin Care, Cosmetic Medicine and Cosmetic Surgery, AMPCo, Sydney, 2006.
11. Thiboutot DM, Strauss JS. Diseases of the Sebaceous Glands. In Burns, Tony; Breathnach Stephen; Cox, Neil; Griffiths, Christopher, Fitzpatrick's Dermatology in General Medicine, (6th Ed.). New York: McGraw-Hill, 2003, 672–687p.
12. Goodman G. Acne and Acne Scarring-the Case for Active and Early Intervention, Aust Fam Physician 2006; 35(7): 503–504p.
13. Purvis D, Robinson E, Merry S, et al. Acne, Anxiety, Depression and Suicide in Teenagers: A Cross-sectional Survey of New Zealand Secondary School Students, J Paediatr Child Healt 2006; 42(12): 793–796p.
14. Picardi A, Mazzotti Eva, Pasquini P. Prevalence and Correlates of Suicidal Ideation among Patients with Skin Disease, J Am Acad Dermatol 2006; 54(3): 420–426p.
15. Nambudripad DS. What are the Common Skin Disorders? Freedom from Eczema, Delta Publishing, 2008, 27p.
16. Van T N, Thi L D, Trong H N, et al . Efficacy of Oral Isotretinoin in Combination with Desloratadine in the Treatment of Common Acne Vulgaris in Vietnamese Patients Maced J Med Sci. 2019 Jan 30; 7(2):217-220.
17. Bergfeld WF. The evaluation and management of acne: economic considerations. J Am Acad Dermatol 1995;32:S52-56.
18. Cohen BA, Prosen P, Schachner AL. Acne.In: Schachner AL, Hansen CR, Editors. Paediatric dermatology, 2nd Edn., Vol.2., NewYork: Churchill Livingstone Inc., 1995. p.661683.
19. Thiboutot DM, Strauss JS. Diseases of sebaceous glands. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Editors. Dermatology in general medicine: 6th Edn., Vol.1, New York: McGraw Hill, 2003. p.672-687.
20. Dogra J, Aneja N, Saxena VN. Oral gugulipid in acne vulgaris management. Ind J Dermatol Venereol Leprol 1990; 56: 381-383.
21. Tan JKL, Vasey K, Fung KY. Beliefs and perceptions of patients with acne. J Am Acad Dermatol 2001; 44 : 439-445.
22. Pearl A, Arnold B, Lello J, Birchal NM. The impact of acne : a study of adolescents attitudes, perceptions and knowledge. NZ Med J 1998; 111: 265-271.
23. Bergler-Czop B, Brzezińska-Wcisło L. Dermatological problems of the puberty. Postep Derm Alergol 2013; 30: 178-187.
24. Tutakne MA, Chari KVR. Acne, Rosacea and perioral dermatitis. In: Valia RG, Valia AR, Editors. IADVL text book and Atlas of dermatology: Mumbai: Bhalani Publishing House, 2001. p.689-710.
25. Dhaher SA, Jasim ZM. The adjunctive effect of desloratadine on the combined azithromycin and isotretinoin in the treatment of severe acne: Randomized clinical trial. J Dermatol Dermatol Surg 2018;22:21-25
26. Lavers, I. Diagnosis and management of Acne vulgaris. Nurse Prescr. 2014, 12, 330–336. [CrossRef]
27. Feldman, S.; Careccia, R.E.; Barham, K.L.; Hancox, J. Diagnosis and treatment of acne. Am. Fam Physician 2004, 69, 2123–2130. [PubMed]
28. Lee HE, Chang IK, Lee Y, Kim CD, Seo YJ, Lee JH, Im M. Effect of antihistamine as an adjuvant treatment of isotretinoin in acne: a randomized, controlled comparative study. Journal of the European Academy of Dermatology and Venereology. 2014; 28(12):1654-1660.
29. Nast A, Bayerl C, Borelli C, Degitz K, Dirschka T, Erdmann R, et al. S2k - Guideline on the therapy of acne. Journal of the German Society of Dermatology 2010;379(9813):361-372.
30. King K, Jones DH, Daltrey D, Cunliffe WJ. The effect of 13-cis retinoic acid on the skin microflora of patients with severe acne. Journal of Investigative Dermatology 1982;78
(4):328. CENTRAL: CN–00321308
31. Pelle E, McCarthy J, Seltmann H, Huang X, Mammone T, Zouboulis CC, et al. Identification of histamine receptors and reduction of squalene levels by an antihistamine in sebocytes. J Invest Dermatol 2008;128:1280-5.
32. Zouboulis CC, Korge B, Akamatsu H, Xia LQ, Schiller S, Gollnick H, et al. Effects of 13-cis-retinoic acid, all-trans-retinoic acid, and acitretin on the proliferation, lipid synthesis and
التنزيلات
منشور
إصدار
القسم
الرخصة
هذا العمل مرخص بموجب Creative Commons Attribution 4.0 International License.
تتبع هذه المجلة سياسة الوصول الحر (Open Access)، حيث تتوفر جميع محتوياتها مجاناً للمستخدمين والمؤسسات. يُسمح للقراء بتحميل الأبحاث، قراءتها، طباعتها، الاقتباس منها، أو البناء عليها، بشرط نَسب العمل إلى أصحابه الأصليين والإشارة إلى المجلة كمنصة للنشر. جميع المواد المنشورة تخضع لترخيص المشاع الإبداعي (نَسب المُصنَّف 4.0 دولي - CC BY 4.0).
